<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    BioDelivery Sciences International, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About BioDelivery Sciences International, Inc.

    BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMAÂŽ) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Herm Cukier
    • FOUNDED
      1997
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Merus N.V.

    Merus N.V.

    Merus is a clinical-stage immuno-oncology company developing innovative full-lengt...

    Merus is a clinical-stage immuno-oncology compa...

    Filing Type:    PU
    Celldex Therapeutics, Inc.

    Celldex Therapeutics, Inc.

    Celldex is developing targeted therapeutics to address devastating diseases for wh...

    Celldex is developing targeted therapeutics to ...

    Filing Type:    PU
    Dermira, Inc.

    Dermira, Inc.

    Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to ...

    Dermira is a biopharmaceutical company dedicate...

    Filing Type:    PU
    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics, Inc.

    Oncternal Therapeutics is a clinical-stage oncology company developing a diverse p...

    Oncternal Therapeutics is a clinical-stage onco...

    Filing Type:    PU
    Prothena Corporation plc

    Prothena Corporation plc

    Prothena Corporation plc (Nasdaq: PRTA) is a clinical-stage neuroscience company f...

    Prothena Corporation plc (Nasdaq: PRTA) is a cl...

    Filing Type:    PU
    Capricor Therapeutics, Inc.

    Capricor Therapeutics, Inc.

    Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology compa...

    Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a...

    Filing Type:    PU
    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc.

    Evelo Biosciences, Inc. is a clinical stage biotechnology company developing oral ...

    Evelo Biosciences, Inc. is a clinical stage bio...

    Filing Type:    PU
    electroCore, Inc.

    electroCore, Inc.

    electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated t...

    electroCore, Inc. is a commercial stage bioelec...

    Filing Type:    PU
    Chiasma, Inc.

    Chiasma, Inc.

    Chiasma is focused on improving the lives of patients who face challenges associat...

    Chiasma is focused on improving the lives of pa...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.